ZymoGenetics regains Recothrom rights outside Canada
This article was originally published in Scrip
Executive Summary
ZymoGenetics has regained the promotional rights to the haemostatic agent Recothrom (topical recombinant thrombin) from Bayer Schering Pharma in all areas outside Canada.